Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Suma Satti"'
Autor:
Veena Shankaran, Joseph M Unger, Amy K Darke, Jennifer Marie Suga, James L Wade, Peter J Kourlas, Sreenivasa R Chandana, Mark A O’Rourke, Suma Satti, Diane Liggett, Dawn L Hershman, Scott D Ramsey
Publikováno v:
J Natl Cancer Inst
Background Financial toxicity is a growing problem in oncology, but no prior studies have prospectively measured the financial impact of cancer treatment in a diverse national cohort of newly diagnosed cancer patients. S1417CD was the first cooperati
Autor:
Victoria Chung, Nakia Lashawn Brooks, Jeffrey Burton, Suma Satti, Lingling Du, Tong Yang, Jonathan Mizrahi
Publikováno v:
Journal of Clinical Oncology. 40:e16242-e16242
e16242 Background: Pancreatic cancer (PC) is a highly fatal disease, and multiple studies have shown that African Americans (AA) have a higher incidence of PC compared with Whites and have a higher risk of PC-related mortality. Differences in known r
Autor:
James L. Wade, Dawn L. Hershman, Scott D. Ramsey, Mark Allen O'Rourke, Jennifer Marie Suga, Veena Shankaran, Diane Liggett, Suma Satti, Sreenivasa R Chandana, Joseph M. Unger, Peter Kourlas, Amy K. Darke
Publikováno v:
Journal of Clinical Oncology. 38:137-137
137 Background: Despite evidence that rising cancer care costs contribute to “financial toxicity” in cancer pts, no studies, to our knowledge, have prospectively assessed the financial impact of cancer diagnosis (dx) using both self-reported and
Autor:
Geoffrey I. Shapiro, Jacob M. Estes, Frank Tsai, Erkut Borazanci, James M. Cleary, Suma Satti, Sunil Sharma, Takumi Kawabe, Justin C. Moser, Lingling Du, Vivek Khemka, Khanh Tu Do, Marc R. Matrana, Valentin Kolmakov
Publikováno v:
Journal of Clinical Oncology. 38:3059-3059
3059 Background: CBP501 is a 12-amino acid G2 checkpoint abrogator and calmodulin-modulating peptide that increases platinum influx into tumor cells and induces tumor immunogenic cell death. CBP501 also suppresses platinum-induced release of cytokine
Autor:
Veena Shankaran, Joseph M. Unger, Amy Darke, Jennifer Marie Suga, James Lloyd Wade, Peter Kourlas, Sreenivasa R Chandana, Mark Allen O'Rourke, Suma Satti, Diane Liggett, Dawn L. Hershman, Scott David Ramsey
Publikováno v:
Journal of Clinical Oncology. 38:7010-7010
7010 Background: Despite evidence that rising cancer care costs are contributing to “financial toxicity” in cancer pts, no studies, to our knowledge, have prospectively assessed the financial impact of cancer diagnosis (dx) using both self-report
Autor:
Brianne A. Voros, Suma Satti, Ryan Patrick Griffin, Yvette Bren-Mattison, Robert A. Ramirez, Marc R. Matrana
Publikováno v:
Journal of Clinical Oncology. 38:TPS635-TPS635
TPS635 Background: Combination chemotherapy (CTx) is the mainstay of treatment for patients with advanced high-grade gastroenteropancreatic neuroendocrine carcinoma (GEPNECs) and large cell neuroendocrine carcinomas (LCNECs) of the lung. Pembrolizuma
Publikováno v:
The Ochsner journal. 17(4)
Late relapse with presentation of metastatic disease5 years after nephrectomy with curative intent is a known behavior of renal cell carcinoma (RCC), but data on outcomes, especially regarding targeted therapies, are limited. In this study, we analyz
Autor:
Rodolfo Montironi, Marc R. Matrana, Stefano Cascinu, Francesco Piva, Matteo Santoni, Suma Satti, Giovanni Principato, Giulia Occhipinti, Matteo Giulietti, Marina Scarpelli, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari
Publikováno v:
Expert Review of Molecular Diagnostics. 15:1201-1210
Several novel recurrent mutations of histone modifying and chromatin remodeling genes have been identified in renal cell carcinoma. These mutations cause loss of function of several genes located in close proximity to VHL and include PBRM1, BAP1 and
Autor:
Khanh T. Do, Frank Tsai, Jacob M. Estes, James M. Cleary, Geoffrey I. Shapiro, Suma Satti, Valentin Kolmakov, Marc R. Matrana, Takumi Kawabe
Publikováno v:
Cancer Research. 79:CT228-CT228
Background: CBP501 is a 12 amino acid calmodulin-modulating peptide that increases platinum influx into tumor cells and induces tumor immunogenic cell death. CBP501 also suppresses platinum-induced release of cytokines, such as IL-6, IL-10 and VEGF,
Autor:
Mark Allen O'Rourke, James L. Wade, Peter Kourlas, Amy K. Darke, Dawn L. Hershman, Sreenivasa R Chandana, Joseph M. Unger, Scott D. Ramsey, Suma Satti, Veena Shankaran, Diane Liggett, Jennifer Marie Suga
Publikováno v:
Journal of Clinical Oncology. 37:TPS6652-TPS6652
TPS6652 Background: Few studies have assessed the financial impact of cancer diagnosis (dx) in diverse patients (pts) and caregivers (cgs) using objective and standard financial measures. S1417CD, led by the SWOG Cancer Research Network, is the first